Neuropathologically validated MRI to tau PET synthesis via Covariate-modulated attention networks
Marcell Borhi, Rong-Kuo Lyu, William J. JagustiD, Jingshen WangiD, Joseph GiorgioiD, Alzheimer’s Disease Neuroimaging Initiative
Abstract
Tau PET is a powerful tool to assess tau pathology in vivo; however, in comparison to MRI, its development is more recent, is rarely available at scale, and substantially more difficult to acquire. Here, we present Covariate-Modulated Attention UNet (CoMA-UNet) to synthesize subject-specific 3D tau PET from T1 MRI while incorporating in the synthesis procedure readily available covariates. Across six external validation datasets, CoMA-UNet reproduced regional patterns of tau PET uptake showing strong agreement with true PET that was generalizable across tracers. Next, we submitted the synthetic tau PET to a series of downstream clinically relevant tasks. First, MMSE associations between the synthetic tau PET were statistically indistinguishable from true PET. Second, the synthetic tau PET achieved out-of-sample diagnostic classification of dementia with an AUROC=0.99. Third, in two independent autopsy cohorts, voxel wise synthetic tau PET images closely followed neuropathologically defined Braak-stages. Fourth, when fine-tuned on a small subset of atypical presentations of AD, CoMA-UNet preserved phenotype-relevant tau topographies and recovered clinically meaningful structure across atypical clinical phenotypes. These findings demonstrate that the novel CoMA-UNet MRI-based synthesis augmented with covariate information can approximate tau PET with sufficient accuracy for downstream scientific and clinical applications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthesizing Images of Tau Pathology from Cross-modal Neuroimaging using Deep Learning
J. Lee, B. J. Burkett, … D. T. Jones·bioRxiv·Sep 7, 2022
- Classifying Mild Cognitive Impairment from Normal Cognition: fMRI Complexity Matches Tau PET Performance
Kay Jann, Gilsoon Park, … Hosung Kim·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Jul 1, 2025
- Data-driven approaches for Tau-PET imaging biomarkers in Alzheimer’s disease
Jacob W. Vogel, Niklas Mattsson, … The Swedish BioFINDER Study·Human Brain MappingPeer-reviewed·Oct 19, 2018
- Amyloid-Tau PET Fusion Reveals Covarying Network Territories Linked to Disease Stage, Cognition, and APOE4 in Alzheimers Disease
Bikesh Bimali, Jiayu Chen, Armin Iraji·bioRxiv·Aug 20, 2026
- Patient-specific functional brain architecture explains cortical patterns of tau PET in Alzheimer's disease
Hamid Behjat, Jacob W. Vogel, … Rik Ossenkoppele·bioRxiv·Oct 2, 2025
- Deep Learning for Alzheimer's Disease: Mapping Large-scale Histological Tau Protein for Neuroimaging Biomarker Validation
Maryana Alegro, Yuheng Chen, … Lea T. Grinberg·bioRxiv·May 27, 2020